Disease Description (Causes and Symptoms)
- Definition: Pancreatic metastasis is a malignant tumor that develops when cancer cells originating in another organ metastasize to the pancreas, rather than being primary pancreatic cancer that begins in the pancreas itself.
- Causes/Pathophysiology: The primary cancer (mainly kidney cancer, lung cancer, breast cancer, stomach/colorectal cancer, melanoma, etc.) reaches and proliferates in the pancreas through the bloodstream, lymphatic system, or direct invasion from adjacent organs. According to available data, the frequency of pancreatic metastasis is approximately 10%, with most cases involving direct invasion from adjacent organs or lymph nodes, while hematogenous metastasis has been reported at approximately 2–3%.
- Main symptoms: Often asymptomatic in the early stages. Symptoms that may occur as the disease progresses include systemic symptoms such as loss of appetite, lethargy, weight loss, fever and sweating, upper abdominal pain, and jaundice (when the bile duct is involved).
Treatment Methods
- General principles: Treatment is determined based on the type and extent of the primary cancer and the patient’s general condition. For pancreatic metastases, the goals are to control symptoms from the metastatic lesion and preserve pancreatic function, and systemic treatment focused on the primary cancer is important.
- Standard treatment options
- Systemic treatment: Chemotherapy according to the primary cancer, targeted therapy (e.g., VEGF/mTOR-targeted therapy for kidney cancer), immune checkpoint inhibitors, etc.
- Surgical resection: Considered for selected indications (e.g., resection may be beneficial for long-term survival in cases such as pancreatic metastasis from renal cell carcinoma with a single metastatic lesion and controlled systemic disease). Total or partial pancreatectomy requires an individualized risk–benefit assessment.
- Local treatment/procedures: Endoscopic or interventional procedures for symptom relief (stent placement by ERCP in cases of biliary obstruction), and in some cases, radiotherapy (for symptom relief) or local radiofrequency ablation may be considered.
- Supportive care: Pain management (analgesics, nerve blocks, etc.), nutritional management, and assistance with the digestion of sugars and fats (pancreatic enzyme replacement), etc.
- Precautions and risk of complications
- When deciding on treatment, the benefits and side effects of options for the primary cancer (surgery, chemotherapy, and immunotherapy) must be considered.
- Risks of postoperative complications during surgery include bleeding, infection, diabetes, and pancreatic exocrine insufficiency.
- When biliary obstruction is present, there is a risk of jaundice and biliary tract infection (cholangitis), so prompt treatment is necessary.
- Systemic side effects of chemotherapy, targeted therapy, and immunotherapy (myelosuppression, risk of infection, immune-related adverse events, etc.) must be monitored.
- Points to note for self-management
- Immediately report changes in symptoms such as weight, food intake, jaundice (yellowing of the eyes or skin), changes in urine/stool color, fever, and chills.
- Follow medication instructions (including anticancer drugs and supportive medications), and prevent infection (wash hands and avoid crowds).
- Symptom management in cooperation with a dietitian and pain specialist is recommended.
Outpatient Visit Checklist (Including Preparation Items and Sample Questions)
- Items to bring to the visit
- A list of all medications currently being taken (including prescription drugs, OTC medicines, and supplements)
- Previous test and imaging results (CT/MRI/PET reports or CDs), and pathology reports (if the primary cancer has been diagnosed)
- Records of recent weight changes and a symptom diary documenting food intake, pain, fever, etc.
- Information on allergies, previous surgeries, and underlying diseases (diabetes, heart disease, etc.)
- Useful records for the consultation
- When symptoms began, their progression, factors that worsen or improve them, and fever patterns
- Changes in urination/bowel movements, indigestion, and findings related to jaundice
- Information to tell the doctor first at the outpatient visit
- A history of recent chemotherapy or immunotherapy
- Whether anticoagulants or antiplatelet agents are being taken
- Whether you are pregnant (if applicable)
Examples of General Questions to Ask the Doctor
- How can you determine whether this lesion came from the primary cancer or is a new primary cancer?
- What are the advantages and disadvantages of the treatment options (surgery, chemotherapy, and immunotherapy), and how do their prognoses differ?
- What are the major side effects of chemotherapy (or targeted therapy/immunotherapy), and how should I prepare for them?
- If biliary obstruction or pain develops, what immediate treatment will I receive?
Examples of Disease-Specific Questions
- In my case, if the primary cancer is kidney cancer (or a specific type of cancer), what survival benefit would surgical resection of the pancreatic metastatic lesion provide?
- If a biopsy of the pancreatic lesion is needed, which method is appropriate: EUS-FNA (endoscopic ultrasound-guided fine-needle aspiration) or ERCP? What are the risks of each method?
Additional reference (Key diagnostic tests summary)
- Blood tests: Liver function tests (including bilirubin), white blood cell count, anemia, tumor markers (nonspecific adjuncts such as CEA and CA 19-9), electrolytes, blood glucose, etc.
- Imaging tests: Abdominal ultrasound, contrast-enhanced CT (including the abdomen and chest), MRI, whole-body PET-CT (search for the primary site and systemic evaluation).
- Biopsy: EUS-FNA (the current standard approach), and, if necessary, tissue biopsy and biliary drainage testing through ERCP. The primary site is differentiated through histology and immunohistochemistry.
(Note: This material is intended to provide general information. The diagnosis and treatment of individual patients should be decided in consultation with the treating physician.)